HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hypothermia for pediatric refractory status epilepticus.

AbstractPURPOSE:
Refractory status epilepticus (RSE) is a life-threatening emergency, demonstrating, by definition, significant pharmacoresistance. We describe five cases of pediatric RSE treated with mild hypothermia.
METHODS:
Retrospective chart review was performed of records of children who received hypothermia for RSE at two tertiary-care pediatric hospitals between 2009 and 2012.
KEY FINDINGS:
Five children with RSE received mild hypothermia (32-35°C). Hypothermia reduced seizure burden during and after treatment in all cases. Prior to initiation of hypothermia, four children (80%) received pentobarbital infusions to treat RSE, but relapsed after pentobarbital discontinuation. No child relapsed after treatment with hypothermia. One child died after redirection of care. Remaining four children were discharged.
SIGNIFICANCE:
This is the largest pediatric case series reporting treatment of RSE with mild hypothermia. Hypothermia decreased seizure burden during and after pediatric RSE and may prevent RSE relapse.
AuthorsKristin Guilliams, Max Rosen, Sandra Buttram, John Zempel, Jose Pineda, Barbara Miller, Michael Shoykhet
JournalEpilepsia (Epilepsia) Vol. 54 Issue 9 Pg. 1586-94 (Sep 2013) ISSN: 1528-1167 [Electronic] United States
PMID23906244 (Publication Type: Journal Article)
CopyrightWiley Periodicals, Inc. © 2013 International League Against Epilepsy.
Chemical References
  • Pentobarbital
Topics
  • Adolescent
  • Child
  • Electroencephalography (methods)
  • Female
  • Humans
  • Hypothermia, Induced
  • Infant
  • Male
  • Pentobarbital (therapeutic use)
  • Retrospective Studies
  • Secondary Prevention
  • Seizures (therapy)
  • Status Epilepticus (therapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: